Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392.SS)
- Previous Close
68.53 - Open
68.41 - Bid 67.19 x --
- Ask 67.20 x --
- Day's Range
66.90 - 68.80 - 52 Week Range
60.23 - 89.89 - Volume
3,684,548 - Avg. Volume
3,113,433 - Market Cap (intraday)
86.699B - Beta (5Y Monthly) 2.25
- PE Ratio (TTM)
-- - EPS (TTM)
-0.06 - Earnings Date Apr 25, 2025
- Forward Dividend & Yield 0.32 (0.47%)
- Ex-Dividend Date Jun 3, 2024
- 1y Target Est
--
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides chemiluminescence series, assembly line series, nucleic acid series, dry type fluorescent immunoassay, and fully automatic blood type analyzer and reagents; ELISA kits; rapid diagnosis; bole series; and supporting reagents. The company was founded in 1991 and is headquartered in Beijing, China.
www.ystwt.comRecent News: 603392.SS
View MorePerformance Overview: 603392.SS
Trailing total returns as of 5/13/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 603392.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 603392.SS
View MoreValuation Measures
Market Cap
86.70B
Enterprise Value
83.16B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
48.62
Price/Book (mrq)
7.10
Enterprise Value/Revenue
43.92
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-3.82%
Return on Assets (ttm)
-1.98%
Return on Equity (ttm)
-0.59%
Revenue (ttm)
1.89B
Net Income Avi to Common (ttm)
-72.25M
Diluted EPS (ttm)
-0.06
Balance Sheet and Cash Flow
Total Cash (mrq)
4.63B
Total Debt/Equity (mrq)
3.00%
Levered Free Cash Flow (ttm)
-544.14M